QUESTCOR PHARMACEUTICALS INC's ticker is QCOR and the CUSIP is 74835Y101. A total of 251 filers reported holding QUESTCOR PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.71 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2014 | $26,437,000 | -7.8% | 285,840 | -35.3% | 0.02% | -5.9% |
Q1 2014 | $28,670,000 | +20.9% | 441,555 | +1.4% | 0.02% | +21.4% |
Q4 2013 | $23,712,000 | -10.2% | 435,474 | -4.3% | 0.01% | -17.6% |
Q3 2013 | $26,404,000 | -25.3% | 455,223 | -41.4% | 0.02% | -29.2% |
Q2 2013 | $35,336,000 | – | 777,269 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 3,296,660 | $149,800,000 | 34.05% |
Valiant Capital Management, L.P. | 913,693 | $41,518,000 | 4.98% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 366,625 | $16,659,000 | 4.35% |
Freshford Capital Management, LLC | 575,000 | $26,128,000 | 3.87% |
Palo Alto Investors LP | 696,297 | $31,640,000 | 3.73% |
RIVULET CAPITAL, LLC | 100,000 | $4,544,000 | 3.62% |
CAPITAL MANAGEMENT CORP /VA | 190,135 | $8,640,000 | 3.59% |
Consonance Capital Management LP | 200,000 | $9,088,000 | 3.23% |
DIALECTIC CAPITAL MANAGEMENT, LP | 407,400 | $18,513,000 | 2.70% |
Freestone Capital Holdings, LLC | 268,738 | $12,211,000 | 2.50% |